Kolkata, Oct 4: The parents of the R.G. Kar Medical College and Hospital, on Saturday, have refuted the latest report of the National Crime Records Bureau (NCRB) published, where Kolkata has been termed as the safest city across the country.

As per the NCRB report, Kolkata for 2023 (latest available) has recorded the lowest cognisable offences per lakh people, which is the fourth time in a row.

On Saturday, while speaking to the media persons, the parents of the R.G. Kar victim rubbished this part of the NCRB report, and claimed that these findings were not based on proper field research and probably the report was prepared to please anyone.

“Was my daughter secured, and that too at her workplace? Was the senior citizen at Kultali in South 24 Parganas district, who became a victim of gang-rape this week, safe? No one is secure here. I do not know who prepared the report. It seems that the report was prepared while sitting in the comfort of the office and without any proper field-based research,” the victim’s mother said.

The victim’s father expressed doubts over the credibility of those in the NCRB who have prepared the report.

“I do not know who in NCRB is responsible for preparing such reports. Even if I believe that the report of Kolkata being the safest city in the country, does that not mean the safety aspect in other Indian cities is unimaginable? I doubt that the NCRB had been misled, and hence the outcome was such a report,” the victim’s father said.

According to him, the only possibility is that the police personnel in Kolkata do not register most of the complaints filed by common people, and hence the crime figures in the city are projected as low.

“We can realise what the reality is since our daughter left. Probably, the experiences are the same,” he added.

As per the latest report of NCRB, Kolkata recorded 83.9 cognisable offences per lakh people in 2023, the lowest among the 19 cities.

Mumbai: Brihanmumbai Municipal Corporation (BMC) Commissioner and Administrator Bhushan Gagrani, on Saturday, inspected key infrastructure projects in Mumbai, including the twin tunnel site at Dadasaheb Phalke Chitranagari in Goregaon under Phase 3(B) of the Goregaon-Mulund Link Road (GMLR) project and the Versova–Bhayander stretch of the Mumbai Coastal Road (North).

During the visit, Gagrani reviewed project layouts, interacted with engineers and issued firm directives to speed up the work. He stressed that all necessary permissions and no-objection certificates (NOCs) for the Coastal Road (North) project must be secured without delay and instructed officials to fast-track land acquisition for areas affected by the alignment.

Deputy Commissioner (Infrastructure) Shashank Bhore, Chief Engineer (Bridges) Uttam Shrote, P North Ward Assistant Commissioner Kundan Valvi, along with other senior officials and project consultants, accompanied him on the inspection.

The BMC chief’s visit also highlighted progress on the six-lane flyover between Dindoshi Court and Dadasaheb Phalke Chitranagari, a crucial part of Phase 3(A) of the GMLR project. Out of 31 planned piers, 27 have already been completed, with work on the remaining four currently underway near Ratnagiri Junction. The flyover, stretching 1,265 meters, is being built using box girders and reinforced concrete and will also feature a pedestrian bridge equipped with escalators.

According to the project timeline, girder launching, deck slab casting, and approach road construction will begin soon. The approach road at Dindoshi Court is expected to be finished by January 31, 2026, while the one at Dadasaheb Phalke Chitranagari will be completed by April 30, 2026. The flyover is targeted to open for traffic by May 16, 2026. Additional Municipal Commissioner (Projects) Abhijeet Bangar also reviewed the project’s progress at the BMC headquarters on Friday.

A senior BMC bridge department official said that of the 26 spans, 12 have been completed, with the remaining 14 scheduled for completion by February 15, 2026. While construction is progressing steadily on most parts, some work on the Mulund side is facing delays due to rehabilitation and land acquisition challenges. Once resolved, the pending flyover work will resume.

The Rs 14,000-crore GMLR project, spanning 12.2 km, will link the Western Express Highway at Goregaon with the Eastern Express Highway at Mulund, slashing travel time between the suburbs from 75 minutes to just 25. Once completed, it promises to deliver seamless east-west connectivity across Mumbai, easing congestion and commuter woes.

Chennai, Oct 4: Authorities have detected adulteration in samples of cough syrups produced by a city-based pharmaceutical company, prompting an immediate halt in production and intensifying regulatory action after recent child deaths in Madhya Pradesh and Rajasthan.

Officials from the Tamil Nadu Food Safety and Drug Administration (FSDA) confirmed that test results of syrups collected during an inspection at the firm’s manufacturing unit in Sunguvarchathram, Kancheepuram district, revealed the medicines were adulterated.

The company has been ordered to explain the findings and cease production until further notice.

The crackdown follows the Tamil Nadu government’s statewide ban on the cough syrup brand Coldrif, enforced from October 1, after concerns that the medicine may have been linked to the death of at least 11 children in Madhya Pradesh and Rajasthan due to suspected kidney failure.

Health authorities have also cleared stocks of the syrup from the local market to prevent further risk.

According to officials, the same manufacturer had supplied its cough syrups to multiple states, including Rajasthan, Madhya Pradesh, and Puducherry, raising concerns about the reach of the potentially unsafe product.

Samples collected last week were sent to state-run laboratories for detailed analysis, and the initial results confirmed contamination.

The ripple effect of the safety scare has been felt across states. On Saturday, the Madhya Pradesh government announced a ban on the sale of Coldrif after nine child deaths were reported since September 7 due to suspected renal failure.

At least 13 children, including cases from Chhindwara and Nagpur, remain under treatment. In Rajasthan, the crisis has triggered administrative action.

The state government suspended its Drug Controller, Rajaram Sharma, following allegations of influencing the process of drug quality determination.

The Rajasthan Medical and Health Department has also halted the supply of 19 medicines manufactured by Jaipur-based Kaysons Pharma until further review and safety clearance.

Health experts say the episode underscores gaps in quality control and the urgent need for stricter oversight of pharmaceutical production and distribution.

Authorities in Tamil Nadu are expected to intensify inspections of local drug makers and coordinate with other states to track and recall any potentially unsafe consignments.

With public safety concerns mounting, officials said further updates on the manufacturer’s explanation and long-term corrective measures will follow once investigations conclude.